Varibar Thin Honey — E-Z-EM Canada Inc drug label update
E-Z-EM Canada Inc updated the drug label for Varibar Thin Honey, a radiopaque contrast agent used in modified barium swallow examinations. The update clarifies its indication for evaluating oral and pharyngeal function and morphology in both adult and pediatric patients.
This update affects E-Z-EM Canada Inc, healthcare providers performing modified barium swallow examinations, and regulatory professionals managing contrast agent labeling.
The explicit inclusion of both adult and pediatric populations in the Indications and Usage section provides regulatory clarity for clinical applications across age groups. This update likely streamlines compliance for facilities using this specific barium sulfate formulation for swallow studies by aligning the label with current clinical practice standards for morphology and function evaluation.
Regulatory and clinical teams should verify that internal protocols and labeling for modified barium swallow examinations reflect the specific indication for both adult and pediatric populations. Quality systems should ensure that the updated Indications and Usage section is integrated into current product documentation.
Varibar Thin Honey (E-Z-EM Canada Inc). 1 INDICATIONS AND USAGE VARIBAR THIN HONEY is indicated for modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR THIN HONEY is a radiopaque contrast agent indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients ( 1 )
Open in openFDA / FDA.gov